Establishment and characterization of docetaxel resistant prostate cancer cell lines

被引：0
|
作者：
Puhr, Martin [1 ]
Oh, Su Jung [1 ]
Erb, Holger [1 ]
Cavarretta, Ilaria T. [1 ]
Hobisch, Alfred [2 ]
Culig, Zoran [1 ]
机构：
[1] Med Univ Innsbruck, A-6020 Innsbruck, Austria
[2] Gen Hosp Feldkirch, Feldkirch, Austria
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-1711
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1711
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Establishment and characterization of a docetaxel-resistant human prostate cancer cell line
    Liu, Jian
    Huang, Yujie
    Zhu, Danyan
    Dai, Yao
    Liu, Dan
    Zhai, You
    Liang, Xingguang
    Wu, Lihua
    Zhao, Qingwei
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [2] Establishment and characterization of paclitaxel-resistant prostate cancer cell lines
    Mizokami, Atsushi
    Takeda, Tadashi
    Izumi, Koji
    Narimoto, Kazutaka
    Li, Yukyo
    Keller, Evan T.
    Zhang, Jian
    Namiki, Mikio
    CANCER RESEARCH, 2006, 66 (08)
  • [3] Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
    O'Neill, Amanda J.
    Prencipe, Maria
    Dowling, Catherine
    Fan, Yue
    Mulrane, Laoighse
    Gallagher, William M.
    O'Connor, Darran
    O'Connor, Robert
    Devery, Aoife
    Corcoran, Claire
    Rani, Sweta
    O'Driscoll, Lorraine
    Fitzpatrick, John M.
    Watson, R. William G.
    MOLECULAR CANCER, 2011, 10 : 126
  • [4] Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
    Amanda J O'Neill
    Maria Prencipe
    Catherine Dowling
    Yue Fan
    Laoighse Mulrane
    William M Gallagher
    Darran O'Connor
    Robert O'Connor
    Aoife Devery
    Claire Corcoran
    Sweta Rani
    Lorraine O'Driscoll
    John M Fitzpatrick
    R William G Watson
    Molecular Cancer, 10
  • [5] Establishment of cabazitaxel-resistant prostate cancer cell lines
    Natsagdorji, Ariunbold
    Machioka, Kazuaki
    Naito, Renato
    Takezawa, Yuta
    Iwamoto, Hiroaki
    Izumi, Kouji
    Kadono, Yoshifumi
    Fujinuma, Shoko
    Mizokami, Atsushi
    CANCER SCIENCE, 2018, 109 : 1071 - 1071
  • [6] Establishment of cabazitaxel-resistant prostate cancer cell lines
    Mizokami, Atsushi
    Machioka, Kazuaki
    Izumi, Kouji
    Aerken, Maolake
    Natsagdorji, Ariunbold
    Kadono, Yoshifumi
    Takezawa, Yuta
    Iwamoto, Hiroaki
    Keller, Evan T.
    CANCER RESEARCH, 2017, 77
  • [7] Establishment and Characterization of Multidrug-resistant Gastric Cancer Cell Lines
    Zhang, Xiaotian
    Yashiro, Masakazu
    Qiu, Hong
    Nishii, Takafumi
    Matsuzaki, Taro
    Hirakawa, Kosei
    ANTICANCER RESEARCH, 2010, 30 (03) : 915 - 921
  • [8] Characterisation of docetaxel resistant breast cancer cell lines
    McDonald, SL
    Moir, SE
    Babalghith, AO
    Stevenson, DAJ
    Heys, SD
    Wallace, HM
    Schofield, AC
    BRITISH JOURNAL OF CANCER, 2003, 88 : S59 - S59
  • [9] Differential gene screening and functional analysis in docetaxel-resistant prostate cancer cell lines
    Ming Wang
    Lei Wang
    Yan Zhang
    Chaoqi Wang
    Shuang Li
    Tao Fan
    OncologyandTranslationalMedicine, 2022, 8 (02) : 94 - 99
  • [10] Contrasted effects of the multitarget TKi vandetanib on docetaxel-sensitive and docetaxel-resistant prostate cancer cell lines
    Guerin, Olivier
    Etienne-Grimaldi, Marie-Christine
    Monteverde, Martino
    Sudaka, Anne
    Brunstein, Marie-Christine
    Formento, Patricia
    Lattanzio, Laura
    Maffi, Monica
    Tonissi, Federica
    Ortholan, Cecile
    Pages, Gilles
    Fischel, Jean-Louis
    Lo Nigro, Cristiana
    Merlano, Marco
    Milano, Gerard
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (08) : 1567 - 1575
12345